Head and neck cancer staging - A review

T. Allis, William Michael Lydiatt

Research output: Contribution to journalReview article

Abstract

Head and neck cancer has substantial world-wide impact. Squamous cell carcinoma (SCC) which comprises greater than 90% of head and neck cancer is found within multiple anatomic subsites and behaves differently then many solid tumors. Treatment failures are most commonly due to local or regional recurrences rather than distant metastasis. Accurate staging of the initial primary and regional lymph nodes is, therefore, critical to assessing the nature and behavior of the disease. For this reason, an international governing body to develop guidelines for staging has evolved since the 1930's. The purpose of this body has been to group patients with head and neck cancer accurately according to the extent of local, regional and distant disease. Continued modifications are required to keep abreast of the changing patterns of disease and treatment. Currently, the TMN staging system is based on anatomic location and size, extent, number and size of regional lymph nodes and presence or absence of distant spread as well as incorporating the resectability of disease. However, the TMN system does have its deficiencies in that it fails to incorporate histology and genetic features that may predict patients' survival more accurately. Future aims to assimilate genetic features, viral associations and concomitant patient co-morbidities into staging systems may benefit patients' therapeutic options and more precisely describe prognosis.

Original languageEnglish (US)
Pages (from-to)133-140
Number of pages8
JournalOtorinolaringologia
Volume59
Issue number3
StatePublished - Sep 1 2009

Fingerprint

Neoplasm Staging
Head and Neck Neoplasms
Lymph Nodes
Treatment Failure
Squamous Cell Carcinoma
Histology
Guidelines
Neoplasm Metastasis
Morbidity
Recurrence
Survival
Therapeutics
Neoplasms

Keywords

  • Diagnosis
  • Head and neck neoplasms
  • Neoplasm staging
  • Squamous cell carcinoma
  • Therapy

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Allis, T., & Lydiatt, W. M. (2009). Head and neck cancer staging - A review. Otorinolaringologia, 59(3), 133-140.

Head and neck cancer staging - A review. / Allis, T.; Lydiatt, William Michael.

In: Otorinolaringologia, Vol. 59, No. 3, 01.09.2009, p. 133-140.

Research output: Contribution to journalReview article

Allis, T & Lydiatt, WM 2009, 'Head and neck cancer staging - A review', Otorinolaringologia, vol. 59, no. 3, pp. 133-140.
Allis T, Lydiatt WM. Head and neck cancer staging - A review. Otorinolaringologia. 2009 Sep 1;59(3):133-140.
Allis, T. ; Lydiatt, William Michael. / Head and neck cancer staging - A review. In: Otorinolaringologia. 2009 ; Vol. 59, No. 3. pp. 133-140.
@article{796080e8acb842168bca77c2bd116771,
title = "Head and neck cancer staging - A review",
abstract = "Head and neck cancer has substantial world-wide impact. Squamous cell carcinoma (SCC) which comprises greater than 90{\%} of head and neck cancer is found within multiple anatomic subsites and behaves differently then many solid tumors. Treatment failures are most commonly due to local or regional recurrences rather than distant metastasis. Accurate staging of the initial primary and regional lymph nodes is, therefore, critical to assessing the nature and behavior of the disease. For this reason, an international governing body to develop guidelines for staging has evolved since the 1930's. The purpose of this body has been to group patients with head and neck cancer accurately according to the extent of local, regional and distant disease. Continued modifications are required to keep abreast of the changing patterns of disease and treatment. Currently, the TMN staging system is based on anatomic location and size, extent, number and size of regional lymph nodes and presence or absence of distant spread as well as incorporating the resectability of disease. However, the TMN system does have its deficiencies in that it fails to incorporate histology and genetic features that may predict patients' survival more accurately. Future aims to assimilate genetic features, viral associations and concomitant patient co-morbidities into staging systems may benefit patients' therapeutic options and more precisely describe prognosis.",
keywords = "Diagnosis, Head and neck neoplasms, Neoplasm staging, Squamous cell carcinoma, Therapy",
author = "T. Allis and Lydiatt, {William Michael}",
year = "2009",
month = "9",
day = "1",
language = "English (US)",
volume = "59",
pages = "133--140",
journal = "Otorinolaringologia",
issn = "0392-6621",
publisher = "Asociatia Medicala Romana",
number = "3",

}

TY - JOUR

T1 - Head and neck cancer staging - A review

AU - Allis, T.

AU - Lydiatt, William Michael

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Head and neck cancer has substantial world-wide impact. Squamous cell carcinoma (SCC) which comprises greater than 90% of head and neck cancer is found within multiple anatomic subsites and behaves differently then many solid tumors. Treatment failures are most commonly due to local or regional recurrences rather than distant metastasis. Accurate staging of the initial primary and regional lymph nodes is, therefore, critical to assessing the nature and behavior of the disease. For this reason, an international governing body to develop guidelines for staging has evolved since the 1930's. The purpose of this body has been to group patients with head and neck cancer accurately according to the extent of local, regional and distant disease. Continued modifications are required to keep abreast of the changing patterns of disease and treatment. Currently, the TMN staging system is based on anatomic location and size, extent, number and size of regional lymph nodes and presence or absence of distant spread as well as incorporating the resectability of disease. However, the TMN system does have its deficiencies in that it fails to incorporate histology and genetic features that may predict patients' survival more accurately. Future aims to assimilate genetic features, viral associations and concomitant patient co-morbidities into staging systems may benefit patients' therapeutic options and more precisely describe prognosis.

AB - Head and neck cancer has substantial world-wide impact. Squamous cell carcinoma (SCC) which comprises greater than 90% of head and neck cancer is found within multiple anatomic subsites and behaves differently then many solid tumors. Treatment failures are most commonly due to local or regional recurrences rather than distant metastasis. Accurate staging of the initial primary and regional lymph nodes is, therefore, critical to assessing the nature and behavior of the disease. For this reason, an international governing body to develop guidelines for staging has evolved since the 1930's. The purpose of this body has been to group patients with head and neck cancer accurately according to the extent of local, regional and distant disease. Continued modifications are required to keep abreast of the changing patterns of disease and treatment. Currently, the TMN staging system is based on anatomic location and size, extent, number and size of regional lymph nodes and presence or absence of distant spread as well as incorporating the resectability of disease. However, the TMN system does have its deficiencies in that it fails to incorporate histology and genetic features that may predict patients' survival more accurately. Future aims to assimilate genetic features, viral associations and concomitant patient co-morbidities into staging systems may benefit patients' therapeutic options and more precisely describe prognosis.

KW - Diagnosis

KW - Head and neck neoplasms

KW - Neoplasm staging

KW - Squamous cell carcinoma

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=76749107449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76749107449&partnerID=8YFLogxK

M3 - Review article

VL - 59

SP - 133

EP - 140

JO - Otorinolaringologia

JF - Otorinolaringologia

SN - 0392-6621

IS - 3

ER -